Intelligent Investor

Medibio Limited (ASX: MEB) - Share Price and Research

- Current share price for MEB : $0.001

MEB General Information +

ASX Code MEB
Website N/A
Industry/Sector n/a
Market Cap ($M) 6
MEB Share Price $0.001
Day High $0.001
Day Low $0.001
Last Close $0.001
MEB Share Price Movement - ( No change )
Prices as at 16:40, 13 Oct 2023
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

MEB Related Research

Medibio Limited (MEB) Upcoming Dividends & Yields

There are no dividends for Medibio Limited (MEB). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Medibio Limited (MEB) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Notification regarding unquoted securities - MEB 13 Oct 2023 5:27PM $0.001 $0.001 $0.001 fallen by 0%
Notification regarding unquoted securities - MEB 13 Oct 2023 5:24PM $0.001 $0.001 $0.001 fallen by 0%
Cleansing Notice 13 Oct 2023 10:17AM $0.001 $0.001 $0.001 fallen by 0%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from Medibio Limited (MEB) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

Medibio Limited (MEB) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
22 Jun 2023 TRIMBOLI, David Issued Indirect Shares 166,666,667 $0.001 $250,000.000
22 Jun 2023 NTOUMENOPOULOS, Christopher Issued Indirect Shares 66,666,667 $0.001 $100,000.000
10 Dec 2021 CARLISLE, Peter Issued Direct Shares 5,989,625 $0.009 $56,250.000

See all changes in directors' interest & trades for Medibio Limited (MEB) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

FAQs about Medibio Limited (MEB)

Medibio Limited's (MEB) current share price is $0.00. This constitutes a price movement of 0% when compared to the share price 7 days ago and is -50% below MEB's 12-month high of $0.00 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.00, Medibio Limited's (MEB) current share price of $0.00 constitutes a movement of or 0%. Medibio Limited's (MEB) share price movement is 0% when compared to 7 days ago and is -50% below MEB's 52-week high of $0.00.

Medibio Limited's (MEB) 52-week high is $0.00 which was reached on 8 May 2023. Relative to this, MEB's current share price of $0.00 constitutes a $0.00 or -50% drop since that high of $0.00 per MEB share.

Medibio Limited's (MEB) 52-week low is $0.00 which was reached on 27 Apr 2023. Relative to this, MEB's current share price of $0.00 constitutes a or 0% drop since that low of $0.00 per MEB share.

Over the last 12 months, Medibio Limited (MEB) has a daily average trading volume of 1,323,666 MEB shares per day.

Medibio Limited (MEB) will release its next Annual Report on n/a. Medibio Limited's (MEB) last annual report was released on 29 Sep 2023. Click here to view Medibio Limited's (MEB) last annual report.

Medibio Limited (MEB) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.